1. Ahmad H., Taylor B V., van der Mei I, Colman S, O'Leary BA, Breslin M, et al. The impact of multiple sclerosis severity on health state utility values: Evidence from Australia. Mult. Scler.. 2017 Jul;23(8):1157–66.
2. Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators’ perspective;Anton;Clin. Pharmacol. Ther.,2017
3. Informing patient-centered care through stakeholder engagement and highly stratified quantitative benefit-harm assessments;Aschmann;Value Heal,2019
4. Aschmann H.E., Puhan M.A., Robbins C.W., Bayliss E.A., Chan W V., Mularski R.A., et al. Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling. HQLO, accept pending minor revis.
5. The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical);Costelloe;J. Neurol. Neurosurg. Psychiatry,2007